Literature DB >> 7616265

The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients.

W C Olivero1, J R Lister, P W Elwood.   

Abstract

Little is known about the natural history and growth rate of asymptomatic meningiomas. To better delineate this problem, the authors reviewed the clinical records and imaging studies of the last 60 patients diagnosed with asymptomatic meningiomas at their institution. There were 45 women and 15 men, whose ages ranged from 38 to 84 years, with a mean age of 66 years. The most common tumor location was convexity (25 patients), but virtually all locations were represented. Three patients were lost to follow up. The average clinical follow-up review of the remaining 57 patients was 32 months (range 6 months to 15 years). None of the patients became symptomatic from an enlarging tumor during their follow-up period. Typically, once a meningioma was diagnosed, follow-up scans were obtained at 3 months, 9 months, and then yearly or every other year thereafter. Forty-five patients underwent follow-up scans, with comparison of tumor size to that found on the initial scan, over a period ranging from 3 months to 15 years. Thirty-five patients have shown no growth in their tumor size, with an average imaging follow up of 29 months (range 3-72 months). Ten patients have shown tumor growth calculated as an increase in the maximum diameter of the tumor. This growth ranged from 0.2 cm over 180 months to 1 cm over 12 months, with an average of 0.24 cm per year. Average imaging follow up for these patients was 47 months (range 6 months to 15 years). The authors conclude that patients with asymptomatic meningiomas need close clinical and radiological follow up to rule out other disease processes and to rule out rapidly enlarging tumors. Although the average follow-up time was short, the vast majority of these tumors appeared to show minimal or no growth over periods of time measured in years. With modern noninvasive imaging techniques, these tumors can be safely observed until they enlarge significantly or become symptomatic.

Entities:  

Mesh:

Year:  1995        PMID: 7616265     DOI: 10.3171/jns.1995.83.2.0222

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  45 in total

1.  Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.

Authors:  M Simon; J Boström; P Koch; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

2.  Validation of self-reported start year of mobile phone use in a Swedish case-control study on radiofrequency fields and acoustic neuroma risk.

Authors:  David Pettersson; Matteo Bottai; Tiit Mathiesen; Michaela Prochazka; Maria Feychting
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-11-05       Impact factor: 5.563

3.  Growth curve analysis of asymptomatic and symptomatic meningiomas.

Authors:  Satoshi Nakasu; Yoko Nakasu; Tadateru Fukami; Junya Jito; Kazuhiko Nozaki
Journal:  J Neurooncol       Date:  2010-08-05       Impact factor: 4.130

4.  Natural history of spheno-orbital meningiomas.

Authors:  Peerooz Saeed; Wouter R van Furth; Michael Tanck; Fabio Kooremans; Nicole Freling; Geert I Streekstra; Noortje I Regensburg; Jan Willem Berkelbach van der Sprenkel; Saskia M Peerdeman; Jakobus J van Overbeeke; Maarten P Mourits
Journal:  Acta Neurochir (Wien)       Date:  2010-12-01       Impact factor: 2.216

5.  The influence of age on the histological grading of meningiomas.

Authors:  Jae-Sung Park; Burak Sade; Soichi Oya; Chong Gue Kim; Joung H Lee
Journal:  Neurosurg Rev       Date:  2014-04-29       Impact factor: 3.042

Review 6.  Contemporary endovascular embolotherapy for meningioma.

Authors:  Gregory J Dubel; Sun Ho Ahn; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

7.  Incidental findings on MRI scans of patients presenting with audiovestibular symptoms.

Authors:  Vasileios Papanikolaou; Mohammad H Khan; Ivan J Keogh
Journal:  BMC Ear Nose Throat Disord       Date:  2010-06-07

8.  Use of sodium fluorescein in skull base tumors.

Authors:  Carlos Eduardo da Silva; Jefferson Luis Braga da Silva; Vinicius Duval da Silva
Journal:  Surg Neurol Int       Date:  2010-10-30

9.  Growth rate of non-operated meningiomas.

Authors:  L A Zeidman; W J Ankenbrandt; Hongyan Du; N Paleologos; N A Vick
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

Review 10.  Management options for cavernous sinus meningiomas.

Authors:  Michael T Walsh; William T Couldwell
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.